European Union Drugs Agency - EUDA

European Union Drugs Agency - EUDA The European Union Drugs Agency (EUDA) is your source of drug-related expertise in Europe. We work alongside our partners to improve EU preparedness on drugs

We prepare and share independent, scientifically validated knowledge, alerts and recommendations.

23/12/2025

❄️ Season’s greetings from the EU Drugs Agency!

As 2025 comes to an end, we look back on a landmark first year under our new, expanded mandate. It has been a year of intense activity: strengthening our monitoring capacity, rolling out new analytical tools and reinforcing how we anticipate emerging drug threats, alert early, respond effectively and learn from evidence.

🙏 Thank you to everyone who collaborated with us this year — policymakers, practitioners, researchers, civil-society partners and communities across Europe.

✨ Looking ahead, 2026 will build on this momentum, with continued developments across our monitoring, preparedness and knowledge services to support a safer, healthier and more resilient Europe.

🎉 We look forward to working together in the year ahead.

📰 The December edition of Drugnet Europe is out!In this issue:✨ A final message from our Executive Director, Alexis Goos...
22/12/2025

📰 The December edition of Drugnet Europe is out!

In this issue:
✨ A final message from our Executive Director, Alexis Goosdeel
🧭 The new EU Drugs Strategy for 2026–2030
🏥 Fresh resources on drug-related hospital emergencies
🎥 Webinar recordings
💼 Job opportunities
… and more insights to round off the year!

🎄 Explore our December updates: https://mailchi.mp/euda/drugnet-europe-195-december2025

👉 Subscribe to Drugnet Europe: https://europa.us7.list-manage.com/subscribe?u=7661463396b2fc9d763392225&id=3f011a8795

🌐 A message that reflects a decade of dedication and leadership, now available in 25 languages!As we mark the end of Ale...
22/12/2025

🌐 A message that reflects a decade of dedication and leadership, now available in 25 languages!

As we mark the end of Alexis Goosdeel's 10 years as Executive Director at the helm of our agency, we are pleased to share his final statement in 25 languages. Throughout his mandate, he consistently promoted international cooperation, evidence-based action and a strong public health approach, helping to strengthen the EU's preparedness and response to drug-related challenges.

Fluent in six languages (French, English, Spanish, Greek, Portuguese and Dutch), he has long championed the importance of making information accessible to people in the languages they use every day. Publishing this message in 25 languages reflects the values he supported and our commitment to a people-centred and multilingual approach.

🔗 Read his final statement in 25 languages:
euda.europa.eu/news/2025/final-statement-alexis-goosdeel-end-his-10-year-mandate_en

To switch between languages, simply use the language selector at the top of the page.

🌍 How do drug related emergencies impact hospitals in neighbouring regions?Our new technical report sheds light on acute...
17/12/2025

🌍 How do drug related emergencies impact hospitals in neighbouring regions?

Our new technical report sheds light on acute drug toxicity cases recorded in 12 emergency departments across the Western Balkans and the EU’s Southern Neighbourhood area.

Some highlights from the 2024 data:
🔹 987 cases reported
🔹 Predominantly young men affected
🔹 Co***ne, cannabis, amphetamine & he**in commonly detected
🔹 NPS still emerging in the region
🔹 Most patients discharged, but 56 deaths recorded

⬇️ Explore the report: euda.europa.eu/publications/technical-reports/collection-drug-related-hospital-emergency-data-western-balkans-and-southern-neighbourhood-countries-euro-den-plus-methodology_en

ℹ️ The study was funded by the European Union under EUDA-implemented technical cooperation projects (EUDA-IPA8 and EU4Monitoring Drugs II).

17/12/2025

🎥 EUDA in action: Building partnerships for preparedness

Take a look inside our recent meeting in Athens, where we co-hosted the EU4Monitoring Drugs II Project Advisory Committee with our Greek national focal point ΕΠΙΨΥ / UMHRI.

For the first time, civil society partners joined the discussion, reinforcing our shared commitment to inclusive, evidence-based drug policies across the European Neighbourhood Policy (ENP) region.

Together, we explored how stronger partnerships can improve preparedness and strengthen drug monitoring systems in Eastern Europe and the Southern Mediterranean.

👉 Learn more about the project: euda.europa.eu/activities/eu4md-ii_en

The meeting was organised under the EU-funded EU4Monitoring Drugs II project implemented by the EUDA.

Good news! You have more time to apply 🎉The Enterprise Architect (AD 6) vacancy has been extended until 2 January 2026.J...
17/12/2025

Good news! You have more time to apply 🎉

The Enterprise Architect (AD 6) vacancy has been extended until 2 January 2026.

Join us and drive the EUDA’s digital transformation.

👉 Details and applications: euda.europa.eu/calls/2025/ad202507_en

EU Careers

💡 How often do drug-related emergencies happen in Europe? Our latest analysis from the European Drug Emergencies Network...
17/12/2025

💡 How often do drug-related emergencies happen in Europe? Our latest analysis from the European Drug Emergencies Network (Euro-DEN Plus) sheds light on thousands of hospital presentations each year.

In 2024, nearly 50 hospitals reported data. Focusing on the 29 hospitals across 19 EU countries and Norway, the new analysis shows:

⚡ Most common substances: co***ne (26%), cannabis (24%) and amphetamine (14%)
👨 Patient profile: men accounted for 75% of cases, mean age 33. Among the younger cases (aged 10-19), girls accounted for a higher proportion (38% compared to 25% overall)
🔄 Polydrug use: 43% involved multiple substances, 22% involved a single drug plus alcohol and 35% involved a single drug (the most common substances reported as a single drug were cannabis, co***ne, GHB/GBL and he**in)
🚑 Emergency response: over two-thirds arrived by ambulance, most discharged directly from the emergency department

🔎 Our interactive data explorer lets you dive deeper into trends by year, hospital, substance, age, s*x, and outcomes.

Explore the full findings and data here: euda.europa.eu/node/31195/latest_en

❓ How do you evaluate drug policy effectively? Our seven-step guide helps policymakers and managers commission and overs...
12/12/2025

❓ How do you evaluate drug policy effectively? Our seven-step guide helps policymakers and managers commission and oversee evaluations that make a real impact.

To make this content more accessible, we have added two new language versions, Spanish and French. Take a look!

📄 Read the guide: https://www.euda.europa.eu/publications/manuals/evaluating-drug-policy_en

🌍 Multilingualism matters. At the EUDA, we believe that communicating in multiple languages is key to sharing evidence a...
12/12/2025

🌍 Multilingualism matters. At the EUDA, we believe that communicating in multiple languages is key to sharing evidence and supporting best practice across Europe and beyond.

🔍 Our European Questionnaire on Drug Use among People Living in Prison (EQDP) and its Methodological guidelines are now available in French, Spanish, Portuguese and Arabic — with more languages coming soon!

These resources help researchers and professionals to gather vital data on drug use in prison settings and to design effective interventions.

Explore the resources:

👉 Questionnaire: euda.europa.eu/publications/technical-reports/european-questionnaire-drug-use-among-prisoners-eqdp_en
👉 Methodological guidelines: euda.europa.eu/publications/technical-reports/european-questionnaire-drug-use-among-prisoners-eqdp-methodological-guidelines_en

12/12/2025

👋 A heartfelt thank you to our Executive Director, Alexis Goosdeel!

At the end of this year, Alexis Goosdeel’s 10-year mandate as Executive Director of the EU Drugs Agency comes to a close. Today, we share his final statement and video message, reflecting on a decade marked by major shifts in Europe’s drug phenomenon — and on the importance of evidence, cooperation and humanity in our shared mission.

Over the past decade, Alexis has guided our transformation from the EMCDDA to the EUDA with a strengthened mandate, championing scientific excellence, preparedness, public-health-centred approaches and strong partnerships across Europe and beyond.

🙏 We thank him for his leadership, integrity and unwavering commitment to building a safer, healthier and more resilient Europe.

🔗 Read his full statement: euda.europa.eu/news/2025/final-statement-alexis-goosdeel-end-his-10-year-mandate_en

🎥 Watch his final video message below!

📅 This week marks our final Management Board meeting of 2025, and the last one attended by our Executive Director Alexis...
11/12/2025

📅 This week marks our final Management Board meeting of 2025, and the last one attended by our Executive Director Alexis Goosdeel, as his mandate comes to an end. It is an important moment as we reflect on our first full year with an expanded mandate and prepare for what is ahead.

Across two days, Board members will:
🔵 Review progress on EUDA services and our ongoing business transformation
🟢 Take key decisions on the 2026 budget and multiannual planning
🟣 Adopt the new EUDA Reitox Alliance
🟠 Discuss EU and international cooperation priorities for the coming years
🟡 Exchange views with incoming Executive Director, Dr Lorraine Nolan

This meeting will help shape our work for 2026 and ensure we remain ready to anticipate, alert, respond and learn.

🔗 Read the full preview: euda.europa.eu/news/2025/euda-management-board-meets-shape-priorities-and-partnerships_en

Endereço

Praça Europa 1, Cais Do Sodré
Lisbon
1249-289

Horário de Funcionamento

Segunda-feira 09:00 - 17:30
Terça-feira 09:00 - 17:00
Quarta-feira 09:00 - 17:30
Quinta-feira 09:00 - 17:30
Sexta-feira 09:00 - 17:00

Telefone

+351211210200

Website

Notificações

Seja o primeiro a receber as novidades e deixe-nos enviar-lhe um email quando European Union Drugs Agency - EUDA publica notícias e promoções. O seu endereço de email não será utilizado para qualquer outro propósito, e pode cancelar a subscrição a qualquer momento.

Entre Em Contato Com A Prática

Envie uma mensagem para European Union Drugs Agency - EUDA:

Atalhos

Compartilhar

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram